Literatur
-
1
Wallace W HB. et al .
Preservation of fertility in children treated for cancer.
Arch Dis Child.
2003;
88
493-496
-
2
Donnez J. et al .
Livebirth after orthotopic transplantation of cryopreserved ovarian tissue.
Lancet.
2004;
364
1405-1410
-
3
Duffner U. et al .
Late effects after therapy of childhood cancer.
Onkologie.
2000;
23
112-118
-
4
Goodwin P J.
Reversible ovarian ablation or chemotherapy: are we ready for quality of life to guide adjuvant treatment decisions in breast cancer?.
J Clin Oncol.
2003;
21
4474-4475
-
5
Wallace W HB. et al .
The radiosensitivity of the human oocyte.
Hum Reprod.
2003;
18
117-121
-
6
Ganz P A. et al .
Breast cancer in younger women: prospective randomized multicenter study on goserelin to prevent chemotherapy induced ovarian failure in young hormone insensitive reproductive and late health effects of treatment.
J Clin Oncol.
2003;
21
4184-4193
-
7
Ataya K. et al .
Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys.
Biol Reprod.
1995;
52
365-372
-
8
Sonmezer M, Oktay K.
Fertility preservation in female patients.
Hum Reprod Update.
2004;
10
251-266
-
9
Emig R. et al .
Ovarschutz und Fertilitätserhalt vor und während der Chemotherapie.
Geburtsh Frauenheilk.
2003;
63
574-576
-
10
Damewood M D, Grochow L B.
Prospects for fertility after chemotherapy or radiation for neoplastic disease.
Fertil Steril.
1986;
45
443-459
-
11
Kalantaridou S N. et al .
Premature ovarian failure.
Endocrinol Metab Clin North Am.
1998;
27
989-1006
-
12
Minton S E, Munster P N.
Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer.
Cancer Control.
2002;
9
466-472
-
13
Upponi S S. et al .
Pregnancy after breast cancer.
Eur J Cancer.
2003;
39
736-741
-
14
Meirow D.
Reproduction post-chemotherapy in young cancer patients.
Mol Cell Endocrinol.
2000;
169
123-131
-
15
Blakely L J. et al .
Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence.
Cancer.
2004;
100
465-469
-
16
Emens L A, Davidson N E.
Adjuvant hormonal therapy for premenopausal women with breast cancer.
Clin Cancer Res.
2003;
9
486S-494S
-
17
Nystedt M. et al .
Side effects of adjuvant endocrine treatment in premenopausal breast cancer patients: a prospective randomized study.
J Clin Oncol.
2003;
21
1836-1844
-
18
Fogelman I. et al .
Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF).
Osteoporos Int.
2003;
14
1001-1006
-
19
Tchen N. et al .
Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.
J Clin Oncol.
2003;
21
4175-4183
-
20
De Haes H. et al .
Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the zoladex early breast cancer research association trialists group.
J Clin Oncol.
2003;
21
4510-4516
-
21
Vehmanen L, Saarto T, Elomaa I. et al .
Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment.
Eur J Cancer.
2001;
37
2373-2378
-
22
Simone J V.
Childhood Leukemia-Successes and Challenges for Survivors.
NEJM.
2003;
349
627-628
-
23
Oktay K, Buyuk E.
Ovarian transplantation in humans: indications, techniques and the risk of reseeding cancer.
E J Obst Gyn Reprod Biol.
2004;
113S
S45-S47
-
25 Picton H M, Gosden R G, Leibo S P. Cryopreservation of oocytes and ovarian tissue. Vayena E, Rowe P, Griffin PD Current practice and controversies in assisted reproduction. Geneva; World Health Organization 2002: 142-151
-
26
Leibo S P, Mazur P.
The role of cooling rates in low-temperature preservation.
Cryobiology.
1971;
8
447-452
-
27
Siebzehnrubl E. et al .
Extension of the concept of extracorporeal fertilization by cryopreservation of impregnated oocytes.
Geburtsh Frauenheilk.
1993;
53
359-365
-
28
Martinez-Madrid B. et al .
Freeze-thawing intact human ovary with its vascular pedicle with a passive cooling device.
Fertil Steril.
2004;
82
1390-1394
-
29
Nawroth F. et al .
Die Vitrifikation.
Frauenarzt.
2005;
46
214-218
-
30
Blumfeld Z.
Gynaecologic concerns for young women exposed to gonadotoxic chemotherapy.
Curr Opin Obst Gynecol.
2003;
15
359-370
-
31
Chian R C.
In-vitro maturation of immature oocytes for infertile women with PCOS.
RBM‐Online.
2004;
8
547-552
-
32
Gosden R G. et al .
Restoration of fertility to oophorectomized sheep by ovarian autografts stored at - 196 degrees C.
Hum Reprod.
1994;
9
597-603
-
33
Gosden R G. et al .
Follicular development from ovarian xenografts in SCID‐mice.
J Reprod Fertil.
1994;
101
619-623
-
34
Oktay K, Aydin B A, Karlikaya G.
A technique for laparoscopic transplantation of frozen-banked ovarian tissue.
Fertil Steril.
2001;
75
1212-1216
-
35
Radford J A. et al .
Orthotopic reimplantation of cryopreserved ovarian cortical strips after high dose chemotherapy for Hodgkin's lymphoma.
Lancet.
2001;
357
1172-1175
-
36
Wells Jr S A. et al .
Transplantation of the parathyreoid glands in man: clinical indications and results.
Surgery.
1975;
78
34-44
-
37
Bosma G C. et al .
A severe combined immunodeficiency mutation in mouse.
Nature.
1983;
301
527-530
-
38
Waxman J H. et al .
Failure to preserve fertility in patients with Hodgkin's disease.
Cancer Chemother Pharmacol.
1987;
19
159-162
-
39
Kreuser E D. et al .
The role of LHRH‐analogues in protecting gonadal functions during chemotherapy and irradiation.
Eur Urol.
1993;
23
157-163
-
40
Blumenfeld Z. et al .
Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy.
Hum Reprod.
1996;
11
1620-1626
-
42
Schneider K TM.
Wissenschaftlich begründete moderne Geburtshilfe.
Gynäkologe.
2003;
35
840-844
-
41
Recchia F, Sica G. et al .
Goserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer: a phase II pilot study.
Anticancer Drugs.
2002;
13
417-424
-
43
Schmidt K LT. et al .
Orthotopic autotransplantation of cryopreserved ovarian tissue to woman cured of cancer - follicular growth, steroid production and oocyte retrival.
RBM‐online.
2004;
8
448-453
-
44
Richtlinien zur Transplantation peripherer Blutstammzellen.
http://www.baek.de/30/Richtlinien/Richtidx/Blutstam_pdf.pdf
Deutsches Ärzteblatt.
1997;
9
-
45 Richtlinie zur Festlegung von Qualitäts- und Sicherheitsstandards für die Spende, Beschaffung, Testung, Verarbeitung, Konservierung, Lagerung und Verteilung von menschlichen Geweben und Zellen (2004/23/EG). http://europa.eu.int/scadplus/leg/de/cha/c11573.htm
-
46
Giersiepen K, Heitmann C, Janhsen K, Lange C.
Gesundheitsberichterstattung des Bundes. Robert Koch-Institut in Zusammenarbeit mit dem Statistischen Bundesamt.
http://www.rki.de/cln_011/nn_226040/DE/Content/GBE/Gesundheitsberichterstattung/GBEDownloadsT/brustkrebs,templateId=raw,property=publicationFile.pdf/brustkrebs
Brustkrebs.
2005;
(25)
-
47
Beckmann M W, Binder H, Dittrich R, Friese K, Gerber B, Gitsch G, Jonat W, Kiechle M, Kreienberg R, v Otte S, Wallwiener D, Wilhelm M, Würfel W, Ortmann O.
Konzeptpapier zur Ovarprotektion an deutschen reproduktionsmedizinischen Universitätszentren.
Geburtshilfe und Frauenheilkunde.
2006;
66
241-251
-
48
Blakeley L J. et al .
Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence.
Cancer.
2004;
100
465-469
-
49
Wolff M, Strowitzki T.
Habituelle Aborte - ein multifaktorielles Krankeitsbild.
Gyn Endokrinol.
2005;
3
7-17
-
50
Babilas K, Ortmann O.
Ovarprotektion bei zytotoxischer Therapie.
Gynäkologe.
2005;
38
342-348
-
51
Silber S J, Lahnahan K M, Levine D J. et al .
Ovarian transplantation between monozygotic twins discordant for premature ovarian failure.
NEJM.
2005;
353
58-63
-
52
Leppä S, Saart T. et al .
Clondronate treatment influences MMP‐2 associated outcome in node positive breast cancer.
Breast Cancer Res Treat.
2005;
90
117-125
-
53 Empfehlungen auf dem 1. Arbeitstreffen „Fertilitätsprotektion“, Heidelberg vom 29. - 30.05.06.
-
54
The Practice Committee of the American Society for Reproductive Medicine .
Ovarian tissue and oocyte cryopreservation.
Fertil Steril.
2005;
2
993-998
-
55
Meirow D, Lewron J, Eldar-Geva T.
Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy.
NEJM.
2005;
353
318-320
-
56
Maltaris T, Dimmler A, Müller A. et al .
The use of an open-freezing system with self-seeding for cryopreservation of mouse ovarian tissue.
Reprod Dom Anim.
2005;
40
250-254
-
57
Siebzehnrubl E, Kohl J, Dittrich R. et al .
Freezing of human ovarian tissue - not the oocytes but the granulosa is the problem.
Mol Cell Endocrinol.
2000;
169
109-111
-
58
Donnez J, Squifflet J, Dolmans M M. et al .
Orthotopic transplantation of fresh ovarian cortex: a report of two cases.
Fertil Steril.
2005;
84
1018e1-3
-
59
Coticchio G, Bonu M A, Borini A. et al .
Oocyte cryopreservation: a biological perspective.
Eur J Obstet Gynecol Reprod Biol.
2004;
115
S2-7
-
60
Maltaris T, Kaya H. et al .
Comparison of xenografting in SCID mice and LIVE/DEAD assay as a predictor of the developmental potential of cryopreserved ovarian tissue.
In Vivo.
2006;
20 (in press)
-
61 Biljan M M, Hemmings R, Brassard N. Fachinformation von Novartis: The Outcome of 150 Babies Following the Treatment With Letrozole or Letrozole and Gonadotropins. Montreal, PQ, Canada; Montreal Fertility Centre 9..12..2005
-
62
www.krebsgesellschaft.de/arbeitsgemeinschaft_gynaekologische_onkologie,18719.html, www.awmf-online.de
.
-
63
von Otte S, Schöpper B, Al Hassani S. et al .
In-vitro-Maturation. Eine Perspektive der assistierten Reproduktion.
Der Gynäkologe.
2004;
37
701-709
-
64
Lee J S, Schover L R, Patridge A H. et al .
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients.
JCO.
2006;
24
1-15
-
65
Steigrad S, Hacker N F, Kolb B.
In vitro fertilization surrogate pregnancy in a patient who underwent radical hysterectomy followed by ovarian transposition, lower abdominal wall radiotherapy, and chemotherapy.
Fertil Steril.
2005;
83
1547-1549
-
66
Bisharah M, Tulandi T.
Laparoscopic preservation of ovarian function: an underused procedure.
Am J Obstet Gynecol.
2003;
188
367-370
-
67
Visvanathan D K, Cutner A S, Cassoni A M, Gaze M, Davies M C.
A new technique of laparoscopic ovariopexy before irradiation.
Fertil Steril.
2003;
79
1204-1206
-
68
Barwijuk A, Jankowska S, Paplicki A.
Laparoscopic anterolateral ovarian transposition before irradiation of chordoma.
Acta Obstet Gynecol Scand.
2005;
84
822-823
-
69
Farber L A, Ames J W, Rush S, Gal D.
Laparoscopic ovarian transposition to preserve ovarian function before pelvic radiation and chemotherapy in a young patient with rectal cancer.
MedGenMed.
2005;
7
66
-
70
Elis A, Tevet A, Yerushalmi R, Blickstein D, Bairy O, Dann E J, Blumenfeld Z, Abraham A, Manor Y, Shpilberg O, Lishner M.
Fertility status among women treated for aggressive non-Hodgkin's lymphoma.
Leuk Lymphoma.
2006;
47
623-627
-
71
Gosden R G, Mullan J, Picton H M, Yin H, Tan S L.
Current perspective on primordial follicle cryopreservation and culture for reproductive medicine.
Hum Reprod Update.
2002;
8
105-110
-
72
Newton H, Aubard Y, Rutherford A, Sharma V, Gosden R.
Low temperature storage and grafting of human ovarian tissue.
Hum Reprod.
1996;
11
1487-1491
-
73
Maltaris T, Dimmler A, Muller A, Binder H, Hoffmann I, Kohl J, Siebzehnrubl E, Beckmann M W, Dittrich R.
The use of an open-freezing system with self-seeding for cryopreservation of mouse ovarian tissue.
Reprod Domest Anim.
2005;
40
250-254
-
74
Dittrich R, Maltaris T.
A simple freezing protocol for the use of an open freezing system for cryopreservation of ovarian tissue.
Cryobiology.
2006;
52
166
-
75
Gandolfi F, Paffoni A, Papasso Brambilla E, Bonetti S, Brevini T A, Ragni G.
Efficiency of equilibrium cooling and vitrification procedures for the cryopreservation of ovarian tissue: comparative analysis between human and animal models.
Fertil Steril.
2006;
85
1150-1156
-
76
Oktay K.
Spontaneous conceptions and live birth after heterotopic ovarian transplantation: is there a germline stem cell connection?.
Hum Reprod.
2006;
21
1345-1348
-
77
Maltaris T, Kaya H, Hoffmann I, Mueller A, Beckmann M W, Dittrich R.
Comparison of xenografting in SCID‐mice and LIVE/DEAD assay as a predictor of the developmental potential of cryopreserved ovarian tissue.
In Vivo.
2006;
20
11-16
-
78
Maltaris T, Beckmann M W, Mueller A, Hoffmann I, Kohl J, Dittrich R.
Significant loss of primordial follicles after prolonged gonadotropin stimulation in xenografts of cryopreserved human ovarian tissue in severe combined immunodeficient mice.
Fertil Steril.
2006 (in press);
-
79 Montag M. Abteilung für gynäkologische Endokrinologie und Reproduktionsmedizin Universitätsklinikum Bonn. Persönliche Mitteilungen. Heidelberg; 2006
-
80 Stellungnahme der Deutschen Ärztekammer vom 04. 05. 2006 zum geplanten Gewebegesetz. http://www.dgho.de/dgho/pdf/gewebe-g/BAeK-Stellungnahme_Gewebegesetz.pdf
.
-
81 Stellungnahme der Deutschen Gesellschaft für Hämatologie und Onkologie vom 30. 04. 2006 zum geplanten Gewebegesetz. http://www.dgho.de/dgho/pdf/gewebe-g/060430_Stellungnahme_DGHO_Gewebegesetz.pdf
.
-
82
Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri D M, Serhal P.
Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?.
BJOG.
2005;
112
1384-1390
-
83
Seli E, Tangir J.
Fertility preservation options for female patients with malignancies.
Curr Opin Obstet Gynecol.
2005;
17
299-308
-
84 Leitlinien der Arbeitsgemeinschaft Gynäologische Onkologie e.V., 2006-06-23, http://www.ago-online.de/load.html
.
Dr. H. Binder
Frauenklinik des Universitätsklinikums Erlangen
Universitätsstraße 21 - 23
91054 Erlangen
eMail: direktion@gyn.imed.uni-erlangen.de
